Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV

AIDS. 2022 Apr 1;36(5):751-753. doi: 10.1097/QAD.0000000000003179.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Neutralizing
  • COVID-19 Drug Treatment*
  • Coronavirus*
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • sotrovimab